Abstract
Quetiapine hemifumarate (QF) is widely used in psychiatry and is associated with regularly
occurring side effects such as dizziness and metabolic problems. Apart from these
typical adverse events the agent has attracted attention for several rare phenomena
(priapism, cholestasis, rhabdomyolysis) that indeed feature anecdotal character, but
are nevertheless indispensable for a comprehensive understanding of the factual risk
profile of quetiapine. We present the first report of aseptic gingivitis associated
with QF in a patient with mental retardation.
Key words
adverse events · - antipsychotic treatment - · inflammation - · second generation
antipsychotics - · side effects
